ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups

July 10, 1981

Radiology Program Has Accredited 1,200 Facilities

May 18, 1990

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

In Brief: New NCAB Members Briefed At Orientation Wogan Resigns From Board; Parry Names NCCP Deputy

September 10, 1982

Gastrointestinal SPORE To Be Recompeted

June 23, 1995